- Research article
- Open Access
Testis transcriptome analysis in male infertility: new insight on the pathogenesis of oligo-azoospermia in cases with and without AZFc microdeletion
BMC Genomics volume 11, Article number: 401 (2010)
About 10% of cases of male infertility are due to the presence of microdeletions within the long arm of the Y chromosome (Yq). Despite the large literature covering this critical issue, very little is known about the pathogenic mechanism leading to spermatogenesis disruption in patients carrying these microdeletions. In order to identify the presence of specific molecular pathways leading to spermatogenic damage, testicular gene expression profiling was carried out by employing a microarray assay in 16 patients carrying an AZFc microdeletion or affected by idiopathic infertility. Hierarchical clustering was performed pooling the data set from 26 experiments (16 patients, 10 replicates).
An intriguing and unexpected finding is that all the samples showing the AZFc deletion cluster together irrespectively of their testicular phenotypes. This cluster, including also four patients affected by idiopathic infertility, showed a downregulation of several genes related to spermatogenesis that are mainly involved in testicular mRNA storage. Interestingly, the four idiopathic patients present in the cluster showed no testicular expression of DAZ despite the absence of AZFc deletion in the peripheral blood.
Our expression profiles analysis indicates that several forms of infertility can be triggered by a common pathogenic mechanism that is likely related to alterations in testicular mRNA storage. Our data suggest that a lack of testicular DAZ gene expression may be the trigger of such mechanism. Furthermore, the presence of AZFc deletions in mosaic or the loss of function of AZFc genes in absence of Yq deletion can perhaps explain these findings. Finally, based on our data, it is intriguing to hypothesize that DAZ gene dysfunctions can account for a larger number of previously thought "idiopathic" infertility cases and investigation of such testicular gene dysfunction can be important to reveal the molecular determinant of infertility than are undetected when only testing Yq deletions in peripheral blood.
Microdeletions of the Y chromosome long arm (Yq) represent the main molecular determinants of male infertility and account for about 10% of cases of non obstructive azoospermia or severe hypospermatogenesis [1–5]. Yq microdeletions involve three Azoospermia Factors (AZF) loci, AZFa, AZFb and AZFc  and remove many genes likely involved in male germ cell development and maintenance . The most frequent deletion of the Y chromosome (AZFc, b2/b4) spans 3.5 Mb and eliminates 21 genes and transcription units of the AZFc region. Among these, the main candidate for spermatogenesis failure is the Deleted in Azoospermia (DAZ) gene, a testis specific gene present in four copies within AZFc and encoding for an RNA binding protein [6, 7]. The AZFc deletion has been associated with wide range of phenotypes ranging from the complete absence of germ cells in the testes (Sertoli cell only syndrome, SCOS) to a relevant reduction of germ cells still including mature sperm (severe hypospermatogenesis, HS), to a maturation spermatogenesis arrest. Despite the large number of studies investigating the prevalence and the molecular basis of these rearrangements, the testicular gene expression of patients carrying Yq deletions is still largely unknown and so are the molecular mechanisms leading to spermatogenesis disruption.
In recent years, expression profiling of human testis has been widely used for the identification of genes that are involved in different key steps of testis development and function [8–10]. However, at the moment, not a single study has investigated the testicular transcriptome of patients who carry Yq microdeletions.
In this study, we analyzed testis expression profiles of 16 infertile patients with different testicular phenotypes, including men carrying AZFc deletions as well as subjects with idiopathic infertility.
In order to discriminate the genes specifically involved in the different pathological phenotypes, we performed a hierarchical clustering of the data set originated from 26 experiments (16 patients, 10 technical replicates) (Table 1). All the AZFc samples clustered together independently from their testis phenotype (SCOS or HS) (Figure 1). The same cluster also contained 4 patients without Yq deletions (3 affected by idiopathic HS and one by idiopathic SCOS). The remaining three patients without Yq deletions showed a different gene expression profile which was not clustered together with AZFc deleted patients. All the testes with normal spermatogenesis clustered appropriately into their group. The cluster containing AZFc-deleted samples was characterized by the presence of 490 transcripts showing at least a 1.7-fold change in expression as compared to testis with normal spermatogenesis (Additional file 1 and 2). Semiquantitative RT-PCR, carried out on selected genes (ACTL7B, LDHC, ODF 1, TSSK2, PRM2, TNP1), confirmed microarray results (additional file 3).
Ingenuity Pathway Analysis (IPA) was carried out to investigate the main functions played by genes that were found to be downregulated (n. = 331, additional file 1) and showed that "Cellular development" and "Reproductive system development and function" were the main functions correlated with these genes (Figure 2). These functional categories contained several genes playing a role in spermatogenesis, fertilization, and determination of the testicular mass, some of which are involved in human and murine male infertility (DDX25 and FKBP6)  (SPAG6)  (Table 2).
When we analyzed the upregulated genes (n = 159, additional file 2), IPA showed that "Cellular growth and proliferation" and "Cell death" were the functions to be involved, whereas "Reproductive system development and function" was less represented (Figure 3, Table 3).
Network analysis of the dowregulated genes that are linked with spermatogenesis showed an interesting network centered on the YBX2 (MSY2) gene, a member of the Y-box gene family that is selectively expressed in male and female germ cells (Figure 4) . We also found an additional network that is centered on the ARNT2 gene and contains other genes critically involved in the spermatogenetic process (CRISP2, TSSK2, MDM4 and EGR4) (Figure 5).
A specific analysis of the DAZ gene signal in the samples represented in the cluster showed that DAZ was not expressed in all the four patients who were not carrying the AZFc deletion (Table 4). These results were confirmed by a RT-PCR analysis carried out as previously described . The same kind of analysis was carried out also for CDY1 and VCY2 genes, mapped in multiple copies within AZFc locus close to the DAZ gene cluster . This analysis evidenced CDY1 expression in patients with idiopathic infertility but not in those with AZFc deletion. On the other hand, an overexpression of VCY2 gene was detected in 4 out of 6 patients with AZFc deletion. A BLAST search using the VCY2 oligonucleotide sequence spotted on the array discovered a 60% homology with the sequence mapped in Yp, corresponding to a portion of the VCY2 exon 7, in addition to the expected 100% homology with VCY2 coding region.
In the present study, we carried out a microarray analysis to investigate testicular gene expression profiles in patients affected by different forms of infertility. Due to the absence or reduced number of germ cells in these patients, a downregulation of genes with prominent or exclusive germ cell expression was expected in all samples, whereas genes expressed mainly in somatic cells were expected to show increased expression. However, the main purpose of this study was to analyze the inter-individual differences among infertile patients, in order to identify specific expression profiles for each different conditions.
Using this approach we found a similar gene expression profile in all the samples originated from individuals carrying the AZFc deletion as well as in four patients with idiopathic infertility. All these case showed a common gene cluster that contained 490 transcripts (331 down- and 159 upregulated genes). Since all HS patients had the same Johnsen score, the difference in the expression profiles of samples present in the cluster and patients outside the cluster cannot be due to a different number of germ cells in their testis, but likely indicates a real difference in the transcription levels of specific genes. Among the downregulated transcripts, we detected several genes involved in spermatogenesis, fertilization, and male infertility. To clarify a potential pathogenic link between the downregulation of these transcripts and spermatogenesis failure, we carried out an IPA network analysis that revealed two interesting networks. The first network is centered on the YBX2 (MSY2) gene, a member of the Y-box gene family that is specifically expressed in male and female germ cells. YBX2 marks specific mRNAs for cytoplasmic storage, stabilization, and suppression of translation . RNA storage is a crucial step during spermatogenesis. RNA synthesis terminates during mid-spermiogenesis and stabilization and storage of mRNAs are key for the encoding of proteins needed during the terminal phases of spermatogenesis . Quite surprisingly, network analysis of the cluster of patients carrying AZFc deletions showed that YBX2 was not present in the cluster, being not significantly downregulated in the samples within the cluster as compared to the other samples not present in the cluster. However, several genes whose activity is regulated by YBX2 were found to be downexpressed in the network. Among these, we found ODF1, TNP1 and PRM2, all genes that play a key role in the postmeiotic phase of the spermatogenesis. ODF1 encodes for proteins located on the outside of the axoneme in the mid piece and principal piece of the mammalian sperm tail, thereby maintaining the passive elastic structures and elastic recoil of the sperm tail. TNP1 is a spermatid-specific product of the haploid genome which replaces histones and is itself replaced in the mature sperm by the protamines. PRM2 encodes for proteins playing a key role in DNA packaging during sperm differentiation. The combined downregulation of all these genes suggests reduced storage of these transcripts during spermatogenesis, via a YBX2- independent process as the YBX2 transcript was not found within the cluster. A possible intriguing hypothesis is that the loss of function of the DAZ gene, the most important gene disrupted by AZFc deletions , leads to a pathogenic defective mRNA storage. Substantiating this idea, RNA-binding proteins encoded by DAZ are known to be required for the translational regulation of gene expression that is essential for gametogenesis [17, 18]. Furthermore, it has been showed that Dazl, the murine homologous of DAZ, plays a role in the transport of specific mRNAs via a dynein motor complex, and that the Dazl-bound mRNAs is stored at specific sites to be available and used for later developmental processes . Therefore we hypothesize that DAZ disruption may represent a possible cause of the reduced storage of important testis transcripts encoded in the first steps of the spermatogenesis.
Interestingly, the second network we analyzed is centered on the ARNT2 gene and contains several genes involved in the spermatogenesis process (CRISP2, TSSK2, MDM4 and EGR4). CRISP2 is a testis-enriched protein localized to the sperm acrosome and tail. TSSK2 encodes a testis-specific serine/threonine kinase and is bound by the human and murine forms of DAZL. EGR4 is a member of the Egr family of zinc-finger transcription factors, and regulates genes critically involved in the early stages of meiosis. Thus, it is intriguing to conceive that also ARNT2 may play an important role in the pathogenesis of infertility in AZFc deleted patients.
The microarray analysis of samples from patients with AZFc deletion also showed the presence of 159 upregulated transcripts. It is interesting to note that only a few of these genes have been previously linked to infertility. A2M, a gene that is encoding for a protease inhibitor, is up-regulated in the testis of the ABP transgenic mouse that shows an impairment of spermatogenesis . Increased expression of HIF1A, an hypoxia-inducible transcription factor, is present in the internal spermatic vein of patients with varicocele . Finally, HMGB1, encoding for a high mobility group protein, works as a pro-inflammatory and antibacterial factor in human testis . These data suggest that the overexpression of genes related to cell growth and proliferation as well as to apoptosis in the testis of patients with AZFc deletions may represent an unspecific mechanism of reaction to testis damage, rather than the cause of defective spermatogenesis.
An unexpected finding of the present study is that the four patients without AZFc deletion are included in the same cluster containing samples from AZFc deleted patients. In order to verify if the presence of an intact AZFc region in peripheral blood actually correlates with a normal testicular DAZ expression, we focused our attention to the presence/absence of the specific signals for this gene on the array in all cases contained in the cluster. Interestingly, no DAZ signal was detected in any of the four patients without AZFc deletion. Lack of DAZ expression was expected in the samples from patients affected by idiopathic SCOS, due to the absence of germ cells, but it was surprisingly found in the 3 patients affected by idiopathic HS.
The lack of DAZ expression in the testis of infertile patients who are not carrying the AZFc deletion in their peripheral blood has been previously reported and interpreted as the result of somatic AZFc rearrangements producing a mosaic in which Yq deletion is present only in testicular cells [14, 23]. Our results strongly confirm this finding, corroborating the hypothesis that a portion of patients classified as affected by idiopathic infertility actually lack DAZ gene expression in their testis, thus showing a pathogenic mechanism similar to the one responsible of infertility in AZFc deleted patients. In order to investigate also other AZFc genes, we analyzed the specific spots for CDY1 and VCY2, in order to verify their expression in patients with and without AZFc deletion. As expected, CDY1 was expressed in infertile patients without AZFc deletion independently fromtheir collocation with or without the cluster, but not in patients with AZFc deletion. On the other hand, expression levels showed by VCY2 gene were inconsistent with those of DAZ and CDY1 genes, being this gene overexpressed in 4 out of the 6 patients with AZFc deletion. In order todisclose the cause of this unexpected result, we performed a Blast search using the VCY2 oligonucleotide sequence spotted on the array, discovering a 60% homology with a sequence mapped within Yp, in addition of the expected 100% homology with VCY2 gene. This Yp sequence matched with the VCY2 exon 7, target of the VCY2 probe present in the array. On the other hand, DAZ and CDY1 probes showed homology only with their target genes. This suggests that the VCY2 oligonucleotide on the array is not specific enough to consider the expression levels of this gene in the context of the present study.
In summary, our study provides the following novel information: i) all patients with AZFc deletions show a similar testis gene expression profile, independently from their SCOS or HS phenotype, suggesting that all AZFc deletions produce a similar transcriptional pattern and that variability in phenotypes is related to environmental or other genetic mechanisms. ii) one half of the patients with idiopathic infertility cluster together with patients with AZFc deletions, suggesting a common pathogenic mechanism. We hypothesize that a crucial link that can explain this phenomenon is the lack of expression of the DAZ gene in the testes these cases. A potential alternative explanation may be related to the presence of an AZFc deletion in mosaic and/or the loss of function of AZFc genes in absence of Yq deletion. If our finding will be confirmed on larger series of patients, DAZ gene dysfunctions may be proved to account for a larger portion of cases of infertility than one could expect by simply analyzing the prevalence of Yq deletions among these subjects; iii) we found that several genes that are mainly related to the postmeiotic phase of the spermatogenesis and have been previously reported as involved in male infertility are dowregulated in patients with AZFc deletions. Given the crucial role played by RNA storage during spermatogenesis, the loss of function of DAZ can translate to a defective mRNA storage in testis with great pathogenic implications. The identification of the molecular mechanisms underlying the spermatogenesis failure in cases characterized by DAZ loss of function will provide useful information for the disclosure of key molecules which could represent in the future the target for personalized drug therapy.
The study was approved by the local Ethics Committee of the University of Padova and was in accordance with the Helsinki II Declaration. All participants were asked for and provided their informed consent. The study population was selected from a cohort of 1436 men presenting idiopathic non obstructive azoospermia or severe hypospermatogenesis (sperm count <2 million/ml) . Exclusion criteria were: drug consumption, fever in the previous 6 months, seminal infections, varicocele, systemic diseases, previous cryptorchidism or orchitis, presence of anti-sperm auto-antibodies, hypogonadotrophic hypogonadism, abuse of androgenic (anabolic) steroids, treatment with chemotherapeutic agents or radiotherapy, testicular tumors, karyotype abnormalities, androgen receptor, INSL3 and RXFP2 gene mutations [24, 25]. Semen analysis was performed according to the World Health Organization guidelines  on at least two occasions separated by three months. The diagnosis of azoospermia was established by pellet analysis after semen centrifugation.
The testicular structure and spermatogenic activity was evaluated with a combination of methods to have the most homogeneous sampling. As a screening procedure, bilateral testicular fine needle aspiration (FNA) was performed as previously described [5, 27]. Testicular phenotype was classified as follows (1) Sertoli cell only syndrome (SCOS): complete absence of all germ cells in both testes; (2) hypospermatogenesis (HS): quantitative reduction in the number of germs cells with still presence of mature spermatozoa; and (3) maturation arrest (MA): normal presence of germ cells until a definite step of spermatogenesis and lack of germ cells in the later stages.
Patients showing normal karyotype were submitted to molecular testing for Yq microdeletions as previously described (5). Only men carrying the AZFc-b2/b4 deletion were included in the microarray analysis.
The final selected sample comprised 16 patients (pats. 1-16): one patient (pat. 1) had idiopathic SCOS, 6 patients (pats. 2-7) had idiopathic severe HS, 3 patients (pats. 8-10) had SCOS and AZFc-b2/b4 deletion, and 3 patients (pats. 11-13) had severe HS and AZFc-b2/b4 deletion. Three men with obstructive azoospermia and normal spermatogenesis were used as controls (pats. 14-16) (Tab. 1).
Selected subjects underwent bilateral testicular biopsy to clearly assess testicular histology and provide RNA for microarray experiments. At least three 3-5 mm fragments per testis were excised, processed for histological analysis, and at least one sample per testis was submerged in 2 ml of RNAlater (Ambion, Austin, TX, USA). Only biopsy specimens showing a homogeneous histopathology of the testis parenchyma and samples yielding high-quality total RNA preparation were included in the analysis. Testicular histology was classified using a modification of the classical scoring procedure employed by Johnsen  as: (1) biopsies obtained from patients with post-testicular obstructions showing complete spermatogenesis, i.e. all stages represented and >20 late spermatids (also referred as "testicular spermatozoa") per seminiferous tubule (score count 10); (2) biopsies showing severe HS in all seminiferous tubules (score count 8); (3) biopsies from patients with SCOS (score count 2).
Testis samples were homogenized using an hand glass potter, and total testis RNA extracted using the SVtotal RNA Izolation System kit (Promega, Madison, WI, USA). The purity and quantity of RNA was assessed using the Agilent 8453 Spectrophotometer (Agilent, Santa Clara, CA, USA). RNA quality was determined by both evaluation of the integrity of rRNA bands using agarose electrophoresis, and absorbtion readings at 260 and 280 nm. Extracted RNA was linearly amplified using the Amino Allyl MessageAmp™ II aRNA Amplification Kit (Ambion, Austin, TX, USA).
Five to ten ug of amplified aRNA was fluorescently labelled with Cy3-Cy5 cyanins and then hybridizated on high-density array (Microcribi Padova, Italy). The Human Array Ready Oligo Set Version 2 contains array able 70mers representing 21,329 well-characterized human genes in two replicates from the UniGene Database. This database is located at the National Center forBiotechnology Information (see http://www.ncbi.nlm.nih.gov/UniGene/). The UniGene database automatically clusters all human GenBank sequences into a non-redundant set of genes. Each cluster in the UniGene Database represents one unique gene. A cluster may contain manysequences, but one representative sequence has been selected based on the longest region of high-quality sequence data. All pathological testis RNAs were hybridized against normal testis RNA samples (patients with obstructive azoospermia and normal spermatogenesis) while the three samples with normal spermatogenesis were hybridized against an home-made RNA universal reference (brain, liver, muscle and lung), to generate a profile of genes specifically expressed in normal testis, for a total of 26 experiments (tab. 1). After hybridization, Cy3-Cy5 fluorescent signals were captured by a Confocal Laser Scanner "ScanArray Express" (Packard BioScience) and analysed using the software "ScanArray Express - MicroArray Analysis System" version 3.0 (Perkin Elmer). Raw data of the performed experiments have been recorded in the GEO public database (accession number: GSE14310).
The values of the median signal intensity from each spot were subtracted from the local median background intensity. For each slide after local background subtraction, a LOWESS algorithm was used for row data normalization to evaluate signal to noise ratio and generate log ratios of sample vs. reference signal. Only spots showing a signal to noise ratio of at least 1.7 were included in the analysis.
Analysis of data obtained by microarray experiments was carried out by means of hierarchical gene clustering  using Cluster 3.0 (open source 2006) and TreeView (Stanford University Labs) software. In order to include in clustering analysis only well measured transcripts, we selected spots with a present call (identified transcripts with measurable expression) in at least 80% of experiments and being > 1.7 fold up- or down regulated in at least 8 experiments. Identified clusters were then analyzed by the Ingenuity Pathways Analysis (IPA) software (Ingenuity Systems, Redwood City, CA), in order to classify genes based on their biological functions and disclose the functional networks connecting specific genes.
Microarray data are deposited in the GEO public database and are accessible without restriction at the following URL: http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?token=bhqhdyekysokofq&acc=GSE14310 (accession number: GSE14310).
Stuppia L, Gatta V, Calabrese G, Guanciali Franchi P, Morizio E, Bombieri C, Mingarelli R, Sforza V, Frajese G, Tenaglia R, Palka G: A quarter of men with idiopathic oligo-azoospermia display chromosomal abnormalities and microdeletions of different types in interval 6 of Yq11. Hum Genet. 1998, 102 (5): 566-70. 10.1007/s004390050741.
McElreavey K, Krausz C: Sex Chromosome Genetics '99. Male infertility and the Y chromosome. Am J Hum Genet. 1999, 64 (4): 928-33. 10.1086/302351.
Foresta C, Moro E, Ferlin A: Y chromosome microdeletions and alterations of spermatogenesis. Endocrine Reviews. 2001, 22: 226-329. 10.1210/er.22.2.226.
Ferlin A, Raicu F, Gatta V, Zuccarello D, Palka G, Foresta C: Male infertility: role of genetic background. Reprod Biomed Online. 2007, 14 (6): 734-45. 10.1016/S1472-6483(10)60677-3.
Ferlin A, Arredi B, Speltra E, Cazzadore C, Selice R, Garolla A, Lenz A, Foresta C: Molecular and clinical characterization of Y chromosome microdeletions in infertile men: a 10-year experience in Italy. J Clin Endocrinol Metab. 2007, 92 (3): 762-70. 10.1210/jc.2006-1981.
Vogt PH, Edelmann A, Kirsch S, Henegariu O, Hirschmann P, Kiesewetter F, Kohn FM, Schill WB, Farah S, Ramos C, Hartmann M, Hartschuh W, Meschede D, Behre HM, Castel A, Nieschlag E, Weidner W, Grone HJ, Jung A, Engel W, Haidl G: Human Y chromosome azoospermia factors (AZF) mapped to different subregions in Yq11. Hum Mol Genet. 1996, 5 (7): 933-43. 10.1093/hmg/5.7.933.
Kuroda-Kawaguchi T, Skaletsky H, Brown LG, Minx PJ, Cordum HS, Waterston RH, Wilson RK, Silber S, Oates R, Rozen S, Page DC, Curoda-Kawaguchi T: The AZFc region of the Y chromosome features massive palindromes and uniform recurrent deletions in infertile men. Nat Genet. 2001, 29 (3): 279-86. 10.1038/ng757.
Ostermeier GC, Dix D, Miller D, Khatri P, Krawetz SA: Spermatozoal RNA profiles of normal fertile men. The Lancet. 2002, 360: 772-777. 10.1016/S0140-6736(02)09899-9.
He Z, Chan WY, Dym M: Microarray technology offers a novel tool for the diagnosis and identification of therapeutic targets for male infertility. Reproduction. 2006, 132: 11-19. 10.1530/rep.1.01070.
Okada H, Tajima A, Shichiri K, Tanaka A, Tanaka K, Inoue I: Genome-wide expression of azoospermia testes demonstrates a specific profile and implicates ART3 in genetic susceptibility. PLoS Genet. 2008, 4 (2): e26-10.1371/journal.pgen.0040026.
Zhang AZ, Yang SY, Ma Y, Lin L, Zhang W: Single nucleotide polymorphisms of the gonadotrophin-regulated testicular helicase (GRTH) gene may be associated with the human spermatogenesis impairment. Hum Reprod. 2006, 21 (3): 755-9.
Sapiro R, Kostetskii I, Olds-Clarke P, Gerton GL, Radice GL, Strauss JF: Male infertility, impaired sperm motility, and hydrocephalus in mice deficient in sperm-associated antigen 6.Mol. Cell Biol. 2002, 22 (17): 6298-305.
Yang J, Morales CR, Medvedev S, Schultz RM, Hecht NB: In the absence of the mouse DNA/RNA-binding protein MSY2, messenger RNA instability leads to spermatogenic arrest. Biol Reprod. 2007, 76 (1): 48-54. 10.1095/biolreprod.106.055095.
Ferlin A, Moro E, Onisto M, Toscano E, Bettella A, Foresta C: Absence of testicular DAZ gene expression in idiopathic severe testiculopathies. Hum Reprod. 1999, 14 (9): 2286-92. 10.1093/humrep/14.9.2286.
Hecht NB: Molecular mechanisms of male germ cell differentiation. BioEssays. 1998, 20: 555-561. 10.1002/(SICI)1521-1878(199807)20:7<555::AID-BIES6>3.0.CO;2-J.
Reijo R, Lee TY, Salo P, Alagappan R, Brown LG, Rosenberg M, Rozen S, Jaffe T, Straus D, Hovatta O, de la Chapelle A, Silber S, Page DC: Diverse spermatogenic defects in humans caused by Y chromosome deletions encompassing a novel RNA-binding protein gene. Nat Genet. 1995, 10: 383-39. 10.1038/ng0895-383.
Collier B, Gorgoni B, Loveridge C, Cooke HJ, Gray NK: The DAZL family proteins are PABP-binding proteins that regulate translation in germ cells. EMBO J. 2005, 24 (14): 2656-66. 10.1038/sj.emboj.7600738.
Reynolds N, Collier B, Maratou K, Bingham V, Speed RM, Taggart M, Semple CA, Gray NK, Cooke HJ: Dazl binds in vivo to specific transcripts and can regulate the pre-meiotic translation of Mvh in germ cells. Hum Mol Genet. 2005, 14 (24): 3899-909. 10.1093/hmg/ddi414.
Lee KH, Lee S, Kim B, Chang S, Kim SW, Paick JS, Rhee K: Dazl can bind to dynein motor complex and may play a role in transport of specific mRNAs. EMBO J. 2006, 25 (18): 4263-70. 10.1038/sj.emboj.7601304.
Petrusz P, Jeyaraj DA, Grossman G: Microarray analysis of androgen-regulated gene expression in testis: the use of the androgen-binding protein (ABP)-transgenic mouse as a model. Reprod Biol Endocrinol. 2005, 3: 70-10.1186/1477-7827-3-70.
Lee JD, Jeng SY, Lee TH: Increased expression of hypoxia-inducible factor-1alpha in the internal spermatic vein of patients with varicocele. J Urol. 2006, 175 (3 Pt 1): 1045-8. 10.1016/S0022-5347(05)00417-9.
Zetterström CK, Strand ML, Söder O: The high mobility group box chromosomal protein 1 is expressed in the human and rat testis where it may function as an antibacterial factor. Hum Reprod. 2006, 21 (11): 2801-9. 10.1093/humrep/del256.
Song NH, Yin CJ, Zhang W, Zhuo ZM, Ding GX, Zhang J, Hua LX, Wu HF: AZF gene expression analysis in peripheral leukocytes and testicular cells from idiopathic infertility. Arch Androl. 2007, 53 (6): 317-24. 10.1080/01485010701730682.
Ferlin A, Bogatcheva NV, Gianesello L, Pepe A, Vinanzi C, Agoulnik AI, Foresta C: Insulin-like factor 3 gene mutations in testicular dysgenesis syndrome: clinical and functional characterization. Mol Hum Reprod. 2006, 12: 401-6. 10.1093/molehr/gal043.
Ferlin A, Vinanzi C, Garolla A, Selice R, Zuccarello D, Cazzadore C, Foresta C: Male infertility and androgen receptor gene mutations: clinical features and identification of seven novel mutations. Clin Endocrinol (Oxf). 2006, 65: 606-10. 10.1111/j.1365-2265.2006.02635.x.
World Health Organization: WHO laboratory manual for the examination of human semen and sperm-cervical mucus interaction. 1999, Cambridge University Press, Cambridge UK
Foresta C, Ferlin A, Bettella A, Rossato M, Varotto A: Diagnostic and clinical features in azoospermia. Clin Endocrinol (Oxf). 1995, 43: 537-43. 10.1111/j.1365-2265.1995.tb02917.x.
Johnsen SG: Testicular biopsy score count--a method for registration of spermatogenesis in human testes: normal values and results in 335 hypogonadal males. Hormones. 1970, 1: 2-25. 10.1159/000178170.
Pasanen T, Saarela J, Saarikko I, Toivanen T, Tolvanen M, Vihinen M, Wong G: DNA microarray data analysis. 1970, CSC - Scientific Computing Ltd, Finland
This study was supported by grants from the Italian Ministry of University and Research (to CF and GP), the University of Chieti (to VG, GP and LS) and the University of Padova (to AF and CF).
The authors are grateful to Stefano L. Sensi for critical reading of the manuscript.
Grant support: This study was supported by grants from the Italian Ministry of University and Research (to CF and GP), the University of Chieti (to VG, GP and LS) and the University of Padova (to AF and CF).
The authors declare that they have no competing interests.
Study design VG, AF, CF, LS; Patients selection: AF, AG, CF, GP; Gene expression analysis: VG, FR, APS; RT-PCR analysis: FR, IA; Manuscript writing: VG, AF, GP, LS. All authors read and approved the final manuscript.
Valentina Gatta, Florina Raicu, Alberto Ferlin contributed equally to this work.
Electronic supplementary material
About this article
Cite this article
Gatta, V., Raicu, F., Ferlin, A. et al. Testis transcriptome analysis in male infertility: new insight on the pathogenesis of oligo-azoospermia in cases with and without AZFc microdeletion. BMC Genomics 11, 401 (2010). https://doi.org/10.1186/1471-2164-11-401
- Ingenuity Pathway Analysis
- Male Infertility
- Normal Spermatogenesis
- Obstructive Azoospermia